You are entering a clinical software system where release mistakes trigger patient-trust consequences, post-acquisition drift is real, and quality governance must reconcile with financed growth immediately. This role exists for a candidate who wants strategic influence, but needs clear eyes about how quickly accountability arrives before full authority does.
Debt-funded clinical platform integration pressure
Recent company financing and acquisition announcements show why this seat exists now: as of May 2026, AirStrip has raised $86.5 million, including a $50 million OrbiMed growth credit facility and preferred investment in October 2025, then moved into back-to-back acquisitions of DECISIO Health in January 2025 and Fifth Eye in June 2025. The company commands more than 675 contracted U.S. hospitals with 166 employees and is scaling an enterprise AI platform toward a 6,000-facility market. That combination puts the board and CEO on an integration-and-scale mandate: unify acquired products into one credible clinical platform, secure investor confidence, and eliminate quality failures that would stall hospital expansion or damage trust with health systems.
Post-acquisition release discipline and defect containment
This role commands the quality control layer across a growing clinical product stack without the permanence of a full-time executive seat. The successful candidate owns release discipline, defect triage, test strategy, audit readiness, and post-acquisition quality normalization across teams with uneven process maturity. Daily execution centers on enforcing standards, isolating failure patterns, documenting risk, and escalating when delivery pressure outruns safe deployment in high-acuity clinical workflows.
Enterprise QA controls across hospital software workflows
- Release Governance: Execute a release control framework that sets entry and exit criteria, enforces defect thresholds, and documents go-live risk across acquired and legacy product lines.
- Defect Containment: Audit production issues, isolate repeat failure modes, and deliver a prioritized corrective action plan tied to patient-safety exposure, customer trust, and deployment stability.
- Integration Normalization: Deploy one QA operating standard across inherited teams from recent acquisitions, including test coverage expectations, escalation paths, and evidence trails for regulated clinical environments.
- Executive Risk Reporting: Command a recurring quality review cadence with product, engineering, and leadership that surfaces unresolved quality debt, staffing gaps, and release-readiness blockers in plain terms.
Clinical software quality leadership thresholds
- Executive QA Tenure: 120+ months leading software quality, test, or release functions, including ownership of enterprise QA programs in healthcare technology, clinical software, or other regulated environments.
- Post-Merger Systems Discipline: Proven record integrating QA standards across multiple product teams, inherited codebases, or acquired organizations where process maturity and decision rights were uneven.
- Risk and Compliance Fluency: Strong command of defect governance, audit documentation, validation evidence, and cross-functional escalation in settings where software reliability affects clinical operations.
Fractional executive compensation for quality accountability
For San Antonio, this pay band anchors the upper tier for part-time quality leadership and reflects the fact that the role carries executive-grade accountability without full-time tenure protection. Local cost of living is more forgiving than Austin or many coastal health-tech markets, but the trade remains clear: this is paid influence, not guaranteed long-term control.
- Base Salary Range: $140000 $190000 USD / Year
- Strategic Access: Direct exposure to board-level quality concerns, post-acquisition operating decisions, and enterprise deployment risk in a 675-hospital customer environment.
- Career Signal: This position converts into future VP Quality, Head of Quality Systems, or operating partner work for healthcare technology companies under scale or integration pressure.
San Antonio presence and fractional terms
- The Physical Presence Directive
- Location: San Antonio, Texas. Status: Remote, with leadership alignment anchored to the San Antonio office and periodic in-person attendance expected for executive coordination.
- Relocation Posture
- Relocation is not the point of this hire. The company is buying targeted executive control over quality outcomes, so local or self-managed travel access matters more than funded relocation.
- The Candidate This Role Is Built For
- This role is built for an ascent-stage quality executive who wants to enter a messy healthcare technology system fast, impose operating discipline, and accept that accountability arrives before full organizational control.
Green Flags
- Advantage: Resume Equity: Stabilizing QA here for 18 months creates a rare signal that the candidate can build a credible quality control function during financed expansion, post-M&A integration, and enterprise clinical scale-up.
- Advantage: Strategic Visibility: Quality sits close to investor confidence, hospital retention, and AI deployment credibility, which gives this seat direct relevance to executive decision-making instead of back-office isolation.
Red Flags
- Warning Sign: Borrowed Authority Risk: This is a fractional seat inside a debt-funded, acquisition-built platform, which means the candidate is answerable for systemic quality debt before staffing, decision rights, and cross-functional compliance are fully aligned.
- Warning Sign: Remote Leash: The role is presented as remote, but executive coordination is tied to San Antonio and periodic in-person attendance. That limits true location freedom and is a hybrid operating reality.
